M Hildinger - JoVE Visualize

Showing results (1-10 of 20) with videos related to

Pageof 2

Sort By:

Journal of Virology|April 10, 1999

Design of 5' untranslated sequences in retroviral vectors developed for medical useM Hildinger, K L Abel, W Ostertag, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 11, 2001

A single-step affinity column for purification of serotype-5 based adeno-associated viral vectorsA Auricchio, E O'Connor, M Hildinger, et al.

Human Gene Therapy|September 19, 2001

Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agentsG Rappa, A Lorico, M Hildinger, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000

Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectorsA Schambach, H Wodrich, M Hildinger, et al.

Human Gene Therapy|February 15, 2001

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow columnA Auricchio, M Hildinger, E O'Connor, et al.

Journal of Virology|June 8, 2001

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transferM Hildinger, A Auricchio, G Gao, et al.

Gene Therapy|May 31, 2003

Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transferJ Cmejlova, M Hildinger, R Cmejla, et al.

Gene Therapy|February 4, 1999

FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cellsM Hildinger, H G Eckert, A J Schilz, et al.

Human Gene Therapy|March 10, 2001

Lack of superinfection interference in retroviral vector producer cellsB Vogt, S Roscher, B Abel, et al.

Human Gene Therapy|February 8, 2003

Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapyS J Reich, A Auricchio, M Hildinger, et al.

Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:

Pageof 2

Journal of Virology|April 10, 1999

Design of 5' untranslated sequences in retroviral vectors developed for medical useM Hildinger, K L Abel, W Ostertag, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 11, 2001

A single-step affinity column for purification of serotype-5 based adeno-associated viral vectorsA Auricchio, E O'Connor, M Hildinger, et al.

Human Gene Therapy|September 19, 2001

Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agentsG Rappa, A Lorico, M Hildinger, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2000

Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectorsA Schambach, H Wodrich, M Hildinger, et al.

Human Gene Therapy|February 15, 2001

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow columnA Auricchio, M Hildinger, E O'Connor, et al.

Journal of Virology|June 8, 2001

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transferM Hildinger, A Auricchio, G Gao, et al.

Gene Therapy|May 31, 2003

Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transferJ Cmejlova, M Hildinger, R Cmejla, et al.

Gene Therapy|February 4, 1999

FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cellsM Hildinger, H G Eckert, A J Schilz, et al.

Human Gene Therapy|March 10, 2001

Lack of superinfection interference in retroviral vector producer cellsB Vogt, S Roscher, B Abel, et al.

Human Gene Therapy|February 8, 2003

Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapyS J Reich, A Auricchio, M Hildinger, et al.

Pageof 2